Skip to main content
. 2021 Feb 6;11(8):3839–3852. doi: 10.7150/thno.53749

Figure 6.

Figure 6

CCL17 is positively associated with tumor progression in human PAs. A, Western blot analysis of CCL17 expression in non-invasive PAs versus invasive PAs. B, CCL17 mRNA expression levels in the non-invasive group (n = 32) and invasive group (n = 32). C, CCL17 expression correlated with tumor size in samples from PA patients (n = 64). D and E, mRNA expression (D) and immunofluorescence (E) of CCL17 in human PA tissue samples according to Knosp grade classification. Original magnification, ×200. Scale bars, 50 µm. All t-tests were two-tailed. Mean ± SEM.